Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: The ‘old’versus the ‘new’Framingham equation

European Journal of Preventive Cardiology

Volumn 18, Issue 1, 2011, Pages 115-120

  Zomer, Ella ^a   Owen, Alice ^a   Magliano, Dianna J ^b   Liew, Danny ^a,c   Reid, Chris ^a  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

AusDiab; cardiovascular disease; Framingham equation; risk prediction

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VALIDATION STUDY; WILCOXON SIGNED RANKS TEST;

ADULT; AGED; ALGORITHMS; AUSTRALIA; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DISCRIMINANT ANALYSIS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79959199375     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32833ace24     Document Type: Article

References (25)

1. World Health Organisation. Cardiovascular Diseases: Fact Sheet No. 317. Geneva, Switzerland: WHO, 2007.
2. Bastuji-Garin S, Deverly A, Moyse D, Castaigne A, Mancia G, de Leeuw PW, et al. The Framingham prediction rule is not valid in aEuropean population of treated hypertensive patients. J Hypertens 2002; 20: 1973–1980.
3. Pyorala K. Cardiovascular risk prediction systems have tobe adapted and updated to current national conditions. Eur J Cardiovasc Prev Rehabil 2006; 13: 674–675.
4. Game FL, Bartlett WA, Bayly GR, Jones AF. Comparative accuracy of cardiovascular riskprediction methods in patients with diabetes mellitus. Diabetes Obes Metab 2001; 3: 279–286.
5. D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use inprimary care: the Framingham Heart Study. Circulation 2008; 117: 743–753.
6. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease riskprofiles. Am Heart J 1991; 121 (1 Pt 2): 293–298.
7. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: theFramingham Study. Am J Public Health Nations Health 1951; 41: 279–281.
8. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease infamilies. The Framingham offspring study. Am JEpidemiol 1979; 110: 281–290.
9. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, et al. The Australian diabetes, obesity and lifestylestudy (AusDiab)-methods and response rates. DiabetesRes Clin Pract 2002; 57: 119–129.
10. Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, Dunstan DW, Colagiuri S, et al. Glucose indices, health behaviors, and incidenceof diabetes in Australia: the Australian diabetes, obesity and lifestylestudy. Diabetes Care 2008; 31: 267–272.
11. Barr EL, Tonkin AM, Welborn TA, Shaw JE. Validity of self-reported cardiovascular diseaseevents in comparison to medical record adjudication and a statewide hospitalmorbidity database: the AusDiab study. Intern Med J 2009; 39: 49–53.
12. Magliano D, Liew D, Pater H, Kirby A, Hunt D, Simes J, et al. Accuracy of the Australian National Death Index:comparison with adjudicated fatal outcomes among Australian participants inthe Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID)study. Aust N ZJ Public Health 2003; 27: 649–653.
13. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardialinfarction in the six months after presentation with acute coronarysyndrome: prospective multinational observational study(GRACE). BMJ 2006; 333: 1091–1091.
14. The Task Force for the Diagnosis andTreatment of Non-ST-Segment Elevation Acute Coronary Syndromes of theEuropean Society of Cardiology. Guidelines for thediagnosis and treatment of non-ST-segment elevation acute coronarysyndromes. Euro Heart J 2007; 28: 1598–1660.
15. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DR Jr, et al. ACC/AHA 2007 Guidelines for the Management ofPatients With Unstable Angina/Non-ST-Elevation Myocardial Infarction, AReport of the American College of Cardiology/American Heart Association TaskForce on Practice Guidelines. J Am Coll Cardiol 2007; 50: e1–e157.
16. Heart Foundation Guide to management ofhypertension. 2008.
17. National Heart Foundation of Australia andthe Cardiac Society of Australia and New Zealand Position Statement on LipidManagement. 2005.
18. National Vascular Disease PreventionAlliance. Guidelines for the assessment of absolute cardiovascular diseaserisk. 2009.
19. Eichler K, Puhan MA, Streurer J, Bachmann LM. Prediction of first coronary events with theFramingham score: a systematic review. Am Heart J 2007; 153: 722–731. 731e1–8).
20. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in theprimary prevention of cardiovascular disease: a systematicreview. Heart 2006; 92: 1 752–1759.
21. Milne R, Gamble G, Whitlock G, Jackson R. Framingham Heart Study risk equation predictsfirst cardiovascular event rates in New Zealanders at the populationlevel. N Z Med J 2003; 116: U662–U662.
22. Marrugat J, D’Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, et al. An adaptation of the Framingham coronary heartdisease function to European Meditteranean area. JEpidemiol Community Health 2003; 57: 634–638.
23. Chow CK, Joshi R, Celermajer DS, Patek A, Neal BC. Recalibration of a Framingham risk equation fora rural population in India. J Epidemiol CommunityHealth 2009; 63: 379–385.
24. Chen L, Tonkin AM, Moon L, Mitchell P, Dobson A, Giles G, et al. Recalibration and validation of the SCORE riskchart in the Australian population: the AusSCORE chart. Eur J Cardiovasc Prev Rehabil 2009; 16: 562–570.
25. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics-2008 update:a report from the American heart association statistics committee and strokestatistics subcommittee. Circulation 2008; 117: e25–e146.